GL1X · GenesisL1 explorer

MolNFT v1 · #136190 · protein

Crystal structure of the first bromodomain of human BRD4 in complex with cyclic vinylogous amide inhibitor MS402

5ULA: “Crystal structure of the first bromodomain of human BRD4 in complex with cyclic vinylogous amide inhibitor…”. X-ray diffraction, 1 ligand (5MJ). MolNFT v1 #136190 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5ULA
Type
protein
Length
241 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
O60885
Ligands
5MJ

Structure

x-ray diffraction · 2 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein119—O60885
B—protein122—O60885

Ligands and binding sites

  • 5MJ · 3-chloranyl-~{N}-(4-methoxyphenyl)-4-[(2-methyl-3-oxidanylidene-cyclopenten-1-yl)amino]benzamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 5ULA · Crystal Structure of the First Bromodomain of Human BRD4 in Complex With Cyclic… · the same entry in another collection · chain A against A, TM-score 1.00
  • O60885 · AlphaFold monomer V2.0 prediction for bromodomain-containing protein 4 (O60885) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.